Dr Reddy's Labs gets USFDA EIR for IPDO facility

Written by Ruchika Sharma Published On 2020-05-29T10:53:35+05:30 | Updated On 29 May 2020 10:53 AM IST

Dr Reddys Labs gets USFDA EIR for IPDO facility

New Delhi: Dr. Reddy''s Laboratories on Thursday said the US health regulator has closed inspection of its Telangana-based facility.

The company has received the establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for Medchal-Malkajgiri-based integrated product development organization (IPDO) indicating closure of the audit, Dr. Reddy''s Laboratories said in a regulatory filing.

The USFDA issues an EIR to a company when an inspection is satisfactorily closed.

Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, committed to providing affordable and innovative medicines for healthier lives.

Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.

The Company's markets include – USA, India, Russia & CIS countries, and Europe.

usfdainspectiondr reddy's labs

Source : PTI

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751